Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05199948 · ClinicalTrials.gov registry record · NA
Weight, Energy, Lipids, and the Liver (WELL) Study
A NA study of Nonalcoholic Fatty Liver, sponsored by Ohio State University.
- Active
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT05199948: Active NA study of Nonalcoholic Fatty Liver, sponsored by Ohio State University.
NCT05199948 is a NA study of Nonalcoholic Fatty Liver that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 74 participants, below the 2,268-participant average among 7 other Nonalcoholic Fatty Liver trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05199948, a NA study of Nonalcoholic Fatty Liver, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
The research study is a parallel arm, randomized placebo-controlled clinical trial designed to assess changes in hepatic lipid accumulation, visceral adipose tissue and postprandial lipid, markers of inflammation and energy metabolism in participants who consume 3 study foods per day for 16 week, while maintaining their body weight.
Primary Outcome
To determine the impact of dietary soybean oil on ectopic liver fat measured through MRI
Conditions Studied
Interventions
- OTHER Soybean Oil Foods
- OTHER Palm Oil Foods
Study Locations (1)
Ohio
- The Ohio State University Human Nutrition Laboratory - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2022-05-02 |
| Est. Completion | 2026-02-01 |
| Phase | NA |
What the registry record for NCT05199948 still lists
NCT05199948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 2,268-participant average among 7 other Nonalcoholic Fatty Liver trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Nonalcoholic Fatty Liver appearing as the primary indexed condition, and to 2 interventions - of which Soybean Oil Foods is the first listed.
NCT05199948 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05199948 about?
NCT05199948 is a clinical study titled "Weight, Energy, Lipids, and the Liver (WELL) Study". The research study is a parallel arm, randomized placebo-controlled clinical trial designed to assess changes in hepatic lipid accumulation, visceral adipose tissue and postprandial lipid, markers of inflammation and energy metabolism in participants who consume 3 study foods per day for 16 week, wh...
What is the current status of trial NCT05199948?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 74 participants. The study started on 2022-05-02. Estimated completion is 2026-02-01.
What conditions does trial NCT05199948 study?
This clinical trial studies the following conditions: Nonalcoholic Fatty Liver.
What interventions are being tested in trial NCT05199948?
The interventions under investigation include: Soybean Oil Foods (OTHER), Palm Oil Foods (OTHER).
Who is sponsoring clinical trial NCT05199948?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05199948 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nonalcoholic Fatty Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
RECRUITING · NA
-
Metabolic Pathology of Pediatric NAFLD
RECRUITING · NA
-
Feasibility of VIIT in Adults With NASH
COMPLETED · NA
-
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
RECRUITING
-
Accurate Point of Care Liver Disease Diagnostics
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI